Kuo-chih Y. Tseng

Hualien City, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

Journal: Hepatology international

Published: June 09, 2026

Reply to the comment on "High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C".

Reply to the comment on "High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: May 07, 2026

Workflow-embedded automation improves hepatitis B screening and safety in b/tsDMARD users.

Workflow-embedded automation improves hepatitis B screening and safety in b/tsDMARD users.

Journal: BMC infectious diseases

Published: February 21, 2026

Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication.

Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication.

Journal: Journal of hepatocellular carcinoma

Published: July 09, 2025

Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study.

Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 03, 2025

A Retrospective Study on Biliary Cooling During Thermal Ablation of Central Liver Tumors in Taiwan.

A Retrospective Study on Biliary Cooling During Thermal Ablation of Central Liver Tumors in Taiwan.

Journal: Cancers

Published: May 02, 2025

Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.

Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.

Journal: The Kaohsiung journal of medical sciences

Published: April 08, 2025

Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).

Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: February 21, 2025

Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Journal: The Kaohsiung journal of medical sciences

Published: February 13, 2025

Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.

Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.

Journal: The lancet. Gastroenterology & hepatology

Published: November 28, 2024

Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program.

Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: November 11, 2024

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study.

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study.

Journal: Clinical and molecular hepatology

Published: November 10, 2024

Showing 1-12 of 103

Last Updated: 09/26/2026